tiprankstipranks
AbCellera Biologics (ABCL)
NASDAQ:ABCL
US Market
ABCL
AbCellera Biologics
RESEARCH TOOLSreports
Want to see ABCL full AI Analyst Report?

AbCellera Biologics (ABCL) Stock News & Sentiment

2,309 Followers
AbCellera: De-Risked Antibody Platform With High-Value Menopause Lead and Underappreciated Pipeline Optionality Supporting Buy Rating
Premium
Ratings
AbCellera: De-Risked Antibody Platform With High-Value Menopause Lead and Underappreciated Pipeline Optionality Supporting Buy Rating
11d ago
ABCL
Abcellera Warns Growing Generative AI Use Raises Cybersecurity, Privacy, and Operational Risks
Premium
Company Announcements
Abcellera Warns Growing Generative AI Use Raises Cybersecurity, Privacy, and Operational Risks
2M ago
ABCL
AbCellera (ABCL) Earnings Call: Liquidity, Risks, Catalysts
Premium
Company Announcements
AbCellera (ABCL) Earnings Call: Liquidity, Risks, Catalysts
2M ago
ABCL
Is ABCL a Buy, Before Earnings?
Premium
Pre-Earnings
Is ABCL a Buy, Before Earnings?
2M ago
ABCL
AbCellera Secures Global Settlement and Patent License Deal
Premium
Company Announcements
AbCellera Secures Global Settlement and Patent License Deal
4M ago
8K
ABCL
Strategic Shift and Promising Antibody Therapeutics Drive Buy Rating for AbCellera Biologics
Premium
Ratings
Strategic Shift and Promising Antibody Therapeutics Drive Buy Rating for AbCellera Biologics
5M ago
ABCL
AbCellera Appoints Dr. Stephen Quake to Board
Premium
Company Announcements
AbCellera Appoints Dr. Stephen Quake to Board
5M ago
8K
ABCL
More ABCL News >

ABCL News on the Web

Analysts Offer Insights on Healthcare Companies: AbCellera Biologics (ABCL), Telix Pharmaceuticals (OtherTLPPF) and Johnson & Johnson (JNJ)
TipRanks News
Bullish
AbCellera: De-Risked Antibody Platform With High-Value Menopause Lead and Underappreciated Pipeline Optionality Supporting Buy Rating
TipRanks News
Neutral
AbCellera initiated with a Buy at JonesResearch
TipRanks News
Bullish
AbCellera Biologics (ABCL) Receives a Buy from Truist Financial
TipRanks News
Neutral
Abcellera Biologics Inc at TD Cowen Healthcare Conference Transcript
GuruFocus News
Neutral
Major Investor Quietly Ramps Up Stake in AbCellera Biologics
TipRanks News
Neutral
Insiders Quietly Double Down on AbCellera Biologics in Bold Buying Spree
TipRanks News
Neutral
Holdings Thermopylae Increases Stake in AbCellera Biologics Inc
GuruFocus News
Neutral

News Score - Last 7 Days

Neutral
ABCL
Sector Average
Media Buzz
This Week1 articles
Weekly Average0.75 articles
News Sentiment
This Week100%
Sector Average70%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is ABCL’s Media Buzz Sentiment?
1 articles about ABCL were published this week. In an average week, 0.75 articles are published.
    What is ABCL’s weekly average amount of articles?
    In an average week, 0.75 articles about ABCL are published.
      What is ABCL’s News Sentiment?
      100% of articles about ABCL were positive this week, compared to its sector average of 70%.
        Healthcare Stocks that are Trending in the News
        TVTXTravere Therapeutics
        HVOOpen Orphan Plc
        PBMPsyence Biomedical
        QDELQuidelOrtho
        Showing the stocks with the most bullish news sentiment over the past week